MindMed (NASDAQ:MNMD) stock is a hot topic on Friday as the company’s shares continue to rally higher. Investors are seeing MNMD stock as a short-squeeze target.
That connection? Jake Freeman, a university student that made $110 million profit selling shares of BBBY stock this week. This comes after BBBY stock went through a massive rally following Ryan Cohen’s RC Ventures purchasing call options earlier this week.
Luckily for Freeman, he sold his shares of BBBY stock during the recent rally. Cohen has since sold his entire stake in the retailer, which has resulted in BBBY stock — as well as other meme stocks — taking a beating today.
With his investment in BBBY having made him so much money, traders are taking notice of Freeman’s other investments. That includes the student and his uncle, Dr. Scott Freeman, taking an activist stake in MNMD stock.
On this news, shares of MNMD stock are seeing incredibly heavy trading Friday. More than 62 million shares of the stock have changed hands as of this writing. That’s well above the daily average trading volume of about 6.6 million shares.
MNMD stock is up slightly Friday afternoon after climbing higher earlier today.
Investors looking for the latest stock market news are in the right place!
We’ve got all of the hottest stock news traders need to know about for Friday! This includes what has shares of 23andMe (NASDAQ:ME), Applied DNA Sciences (NASDAQ:APDN) and Rivian Automotive (NASDAQ:RIVN) stock on the move today. You can read up on all of that news at the links below!
More Friday Stock Market News
- CFO Transition Rocks 23andMe (ME) Stock
- Applied DNA (APDN) Stock Jumps on Monkeypox Test News
- Rivian (RIVN) Stock Falls on Plans to Cut Lower-Cost EVs
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
On the date of publication, William White did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.